Literature DB >> 35059539

Cholangioscopy-guided double-guidewire technique for complex malignant hilar obstruction.

Margaret G Keane1, Bachir Ghandour1, Michael Bejjani1, Manol Jovani1, Mouen A Khashab1.   

Abstract

Video 1Cholangioscopy-guided double-guidewire technique for the management of complex malignant hilar obstruction.
© 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc.

Entities:  

Year:  2021        PMID: 35059539      PMCID: PMC8755521          DOI: 10.1016/j.vgie.2021.10.003

Source DB:  PubMed          Journal:  VideoGIE        ISSN: 2468-4481


  5 in total

1.  Digital single-operator cholangioscopy: a useful tool for selective guidewire placements across complex biliary strictures.

Authors:  Arne Bokemeyer; Dina Gross; Markus Brückner; Tobias Nowacki; Dominik Bettenworth; Hartmut Schmidt; Hauke Heinzow; Iyad Kabar; Hansjoerg Ullerich; Frank Lenze
Journal:  Surg Endosc       Date:  2018-07-13       Impact factor: 4.584

2.  Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment.

Authors:  Ariane Vienne; Ehlam Hobeika; Hervé Gouya; Nathanael Lapidus; Jacques Fritsch; André Daniel Choury; Ariane Chryssostalis; Marianne Gaudric; Gilles Pelletier; Catherine Buffet; Stanislas Chaussade; Frédéric Prat
Journal:  Gastrointest Endosc       Date:  2010-10       Impact factor: 9.427

3.  Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture.

Authors:  H J Kim; M H Kim; S K Lee; K S Yoo; D W Seo; Y I Min
Journal:  Gastrointest Endosc       Date:  2000-11       Impact factor: 9.427

4.  Cholangioscopic findings in bile duct tumors.

Authors:  D W Seo; S K Lee; K S Yoo; G H Kang; M H Kim; D J Suh; Y I Min
Journal:  Gastrointest Endosc       Date:  2000-11       Impact factor: 9.427

Review 5.  Management of hilar biliary strictures.

Authors:  Alberto Larghi; Andrea Tringali; Piera G Lecca; Marco Giordano; Guido Costamagna
Journal:  Am J Gastroenterol       Date:  2007-11-19       Impact factor: 10.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.